|
1
|
Parada LF, Tabin CJ, Shis C and Weinberg
RA: Human EJ bladder carcinoma oncogene is homologue of Harvey
sarcoma virus ras gene. Nature. 297:474–478. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fernández-Medarde A and Santos E: Ras in
cancer and developmental diseases. Genes Cancer. 2:344–358.
2011.
|
|
3
|
Cox AD and Der CJ: Ras history: the saga
continues. Small Gtpases. 1:2–27. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jin H, Wang X, Ying J, Wong AH, Cui Y,
Srivastava G, Shen ZY, Li EM, Zhang Q, Jin J, Kupzig S, Chan AT,
Cullen PJ and Tao Q: Epigenetic silencing of
Ca2+-regulated Ras GTPase-activating protein RASAL
defines a new mechanism of Ras activation in human cancers. Proc
Natl Acad Sci USA. 104:12353–12358. 2007.
|
|
5
|
Ohta M, Seto M, Ijichi H, Miyabayashi K,
Kudo Y, Mohri D, Asaoka Y, Tada M, Tanaka Y, Ikenoue T, Kanai F,
Kawabe T and Omata M: Decreased expression of the Ras
GTPase-activating protein RASAL1 is associated with colorectal
tumor progression. Gastroenterology. 136:206–216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bernards A and Settleman J: Loss of the
Ras regulator RASAL1: another route to Ras activation in colorectal
cancer. Gastroenterology. 136:46–48. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang YW, Qu Y, Li JF, Chen XH, Liu BY, Gu
QL and Zhu ZG: In vitro and in vivo evidence of
metallopanstimulin-1 in gastric cancer progression and
tumorigenicity. Clin Cancer Res. 12:4965–4973. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Malumbres M and Barbacid M: RAS oncogenes:
the first 30 years. Nat Rev Cancer. 3:459–465. 2003.PubMed/NCBI
|
|
9
|
Karnoub AE and Weinberg RA: Ras oncogenes:
split personalities. Nat Rev Mol Cell Biol. 9:517–531. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kimura K, Nagasaka T, Hoshizima N,
Sasamoto H, Notohara K, Takeda M, Kominami K, Iishii T, Tanaka N
and Matsubara N: No duplicate KRAS mutation is identified on the
same allele in gastric or colorectal cancer cells with multiple
KRAS mutations. J Int Med Res. 35:450–457. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu ZM, Liu LN, Li M, Zhang QP, Cheng SH
and Lu S: Mutation detection of KRAS by high-resolution melting
analysis in Chinese with gastric cancer. Oncol Rep. 22:515–520.
2009.PubMed/NCBI
|
|
12
|
Calvisi DF, Ladu S, Conner EA, Seo D,
Hsieh JT, Factor VM and Thorgeirsson SS: Inactivation of Ras
GTPase-activating proteins promotes unrestrained activity of
wild-type Ras in human liver cancer. J Hepatol. 54:311–319. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kong Z, Xie D, Boike T, Raghavan P, Burma
S, Chen DJ, Habib AA, Chakraborty A, Hsieh JT and Saha D:
Downregulation of human DAB2IP gene expression in prostate cancer
cells results in resistance to ionizing radiation. Cancer Res.
70:2829–2839. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vigil D, Cherfils J, Rossman KL and Der
CJ: Ras superfamily GEFs and GAPs: validated and tractable targets
for cancer therapy? Nat Rev Cancer. 10:842–857. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bos JL, Rehmann H and Wittinghofer A: GEFs
and GAPs: critical elements in the control of small G proteins.
Cell. 129:865–877. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Iwashita S and Song SY: Ras GAPs: a
crucial regulator of extracellular stimuli for homeostasis of
cellular functions. Mol Biosyst. 4:213–222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hölzel M, Huang S, Koster J, Ora I,
Lakeman A, Caron H, Nijkamp W, Xie J, Callens T, Asgharzadeh S,
Seeger RC, Messiaen L, Versteeg R and Bernards R: NF1 is a tumor
suppressor in neuroblastoma that determines retinoic acid response
and disease outcome. Cell. 142:218–229. 2010.PubMed/NCBI
|
|
18
|
Seto M, Ohta M, Ikenoue T, Sugimoto T,
Asaoka Y, Tada M, Mohri D, Kudo Y, Ijichi H, Tateishi K, Otsuka M,
Hirata Y, Maeda S, Koike K and Omata M: Reduced expression of RAS
protein activator like-1 in gastric cancer. Int J Cancer.
128:1293–1302. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Q, Walker SA, Gao D, Taylor JA, Dai
YF, Arkell RS, Bootman MD, Roderick HL, Cullen PJ and Lockyer PJ:
CAPRI and RASAL impose different modes of information processing on
RAS due to contrasting temporal filtering of Ca2+. J
Cell Biol. 170:183–190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kolfschoten IG, van Leeuwen B, Berns K,
Mullenders J, Beijersbergen RL, Bernards R, Voorhoeve PM and Agami
R: A genetic screen identifies PITX1 as a suppressor of RAS
activity and tumorigenicity. Cell. 121:849–858. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen YN, Chen H, Xu Y, Zhang X and Luo Y:
Expression of pituitary homeobox 1 gene in human gastric
carcinogenesis and its clinicopathological significance. World J
Gastroenterol. 14:292–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
